JLHL · Jupiter Life Line Hospitals Ltd · Healthcare Facilities
JLHL · Jupiter Life Line Hospitals Ltd · Healthcare Facilities
As of 05 Nov close
Prices adjusted for split on 23 Jul 2026.
52-week range
15.7% below 52-week high
52-week range: as of 05 Nov 2026 close.
Price chartDaily closes on the stock page.
Weighted combination of 8 measured readings. Not a probability, a rating or a forecast.
Full signal detail →Fundamentals as of 15 Sep 2026 · the company's own latest record is 52 days old
Revenue (latest Q)
₹411 Cr
Revenue YoY
PAT YoY
-14.5%
Operating margin
Revenue, last 6 quarters
P/E (TTM)
P/B
5.8
P/S (TTM)
5.9
Sector P/E
29.7
Dividend yield
+0.1%
| Company | P/E | P/B | Net margin | ROE | D/E | Div. yield |
|---|---|---|---|---|---|---|
| JLHL (this stock) | 49.7 | 5.8 | +12.0% | +12.2% | 0.38 | +0.1% |
| Apollo Hospitals Enterprise | 65.8 | 13.6 | +7.8% | +21.9% | 53.8 | +0.2% |
| Max Healthcare Institute | 70.9 | 9.8 | +17.2% | +14.3% | 27.71 | +0.2% |
| Fortis Healthcare | 69 | 14.6 | +11.0% | +10.6% | 0.35 | +0.1% |
Promoter
stable
FII
rising 1q
MF
10.89% (-0.08pp)
falling 2q
Insider trades
No insider trades in the last 12 months.
Bulk/block deals
No bulk/block deals in the last 12 months.
News timeline
No related news.
Concalls & investor presentations
AI-generatedKey takeaway: The investor presentation for Jupiter Life Line Hospitals Limited (JLHL) for the quarter and half year ended September 30, 2026, outlines the company's financial performance and strategic initiatives. Management reported that the acquisition of land for the Pune South hospital was approved, with a total consideration of Rs 150 cr, reducing incremental cash outflow to Rs 100 cr. Construction at Pune South is on schedule, while Mira Road and BKC projects are in regulatory approval stages. The Dombivli hospital saw higher occupancy due to increased infectious-disease cases, narrowing its EBITDA loss to Rs 0.2 cr in Q2FY27 compared to Rs 9.5 cr in Q1FY27. Financial highlights show Total Income of Rs 456.5 cr in Q2FY27, with EBITDA at Rs 106.9 cr. For H1FY27, Total Income reached Rs 867.5 cr, with EBITDA at Rs 186.2 cr. The company noted higher depreciation and finance costs due to capitalization of new beds and ongoing capex. Strategic priorities include scaling bed capacity from 1,700 to 2,900, with phased commissioning of new hospitals. The presentation includes cautionary statements about forward-looking information and risks associated with future performance.
The document presents factual financial results and strategic plans without overtly positive or negative language.
Sourced from an exchange-filed presentation, dated 23 Oct 2026. Summary is RedixFi-generated and distinct from investment advice.
Key takeaway: The earnings conference call for Jupiter Life Line Hospitals Limited on August 3, 2026, provided updates on the company's Q1 FY27 performance. Management reported that the Dombivli Hospital completed its first full quarter of operations, contributing an INR9.5 crores drag on EBITDA, which was anticipated. Total income for the quarter was INR411 crores, with an EBITDA of INR79.3 crores and a margin of 19.3%. The average occupancy rate was 59.6%. Management discussed the performance of existing units, indicating that Thane and Pune hospitals were operating at mid-70% and mid-60% occupancy, respectively. They also addressed questions regarding the Indore unit's expansion and the impact of unbilled revenues. Management confirmed ongoing doctor hiring at Dombivli and discussed the strategic acquisition of a manufacturing plant for backward integration of their pharmacy unit. The call concluded with management expressing confidence in future growth despite current challenges.
The document presented a balanced view of the company's performance and future plans.
Sourced from an exchange-filed transcript, dated 07 Aug 2026. Summary is RedixFi-generated and distinct from investment advice.
Key takeaway: The investor presentation for Jupiter Life Line Hospitals Limited reported on the company's performance for the quarter ended June 30, 2026. Management highlighted that the Dombivli hospital completed its first full quarter of operations, with increasing occupancy supported by patient footfall and expanded clinical services. The presentation noted an EBITDA loss of Rs 9.5 crore from Dombivli, aligning with internal projections. Financial results showed total income of Rs 411.0 crore, a 16.4% increase year-over-year, while PAT decreased by 14.7% to Rs 37.5 crore. Management discussed ongoing projects in Pune South, Mira Road, and BKC, and outlined a plan to scale bed capacity from 1,700 to 2,900 beds. The funding philosophy emphasized a cash flow to EBITDA conversion averaging 75-80% over the last five years to support expansion capex.
The presentation provided a balanced overview of operational performance and ongoing projects without strong emphasis on positive or negative aspects.
Sourced from an exchange-filed presentation, dated 31 Jul 2026. Summary is RedixFi-generated and distinct from investment advice.
Key takeaway: The earnings conference call for Jupiter Life Line Hospitals Limited on May 18, 2026, highlighted significant achievements in FY26, including the early inauguration of the Dombivli hospital, which was completed ahead of schedule. Management reported that the new facility has received positive initial responses from the community and is undergoing accreditation processes. The company is expanding its capacity with plans for additional hospitals in Pune South and Mira Road, aiming for a total of approximately 1,700 new beds. Financially, total income for FY26 reached INR1,499.8 crores, a 15.2% increase year-on-year, with EBITDA of INR343.3 crores and a PAT of INR194.2 crores. Management noted strong operating cash flows and a cash-positive balance sheet despite significant capital expenditures. The call concluded with management expressing confidence in future growth and operational stability.
Management emphasized strong growth and successful project completions.
Sourced from an exchange-filed transcript, dated 21 May 2026. Summary is RedixFi-generated and distinct from investment advice.
Key takeaway: The investor presentation for Jupiter Life Line Hospitals Limited reported on the company's financial results for the quarter and year ended March 31, 2026. Management highlighted significant milestones, including the acquisition of land for a new 400-bed hospital in BKC and the operationalization of the Dombivli hospital ahead of schedule. The presentation noted that the financial performance was impacted by operational losses from the Dombivli hospital and increased depreciation costs. Total income for FY26 was reported at Rs 1,499.8 crore, reflecting a 15.2% increase year-over-year. EBITDA was affected by initial ramp-up losses, while PAT showed a slight increase to Rs 194.2 crore. The company outlined plans for further expansion, aiming to scale bed capacity to 2,900 across various locations, including ongoing projects in Pune and Mira-Bhayandar.
The presentation included both positive milestones and challenges impacting financial performance.
Sourced from an exchange-filed presentation, dated 15 May 2026. Summary is RedixFi-generated and distinct from investment advice.
Key takeaway: During the Q3 and 9M FY26 earnings conference call held on February 2, 2026, management reported that the new hospital in Dombivli is set to launch on February 15, 2026, with a completed construction of 500 beds at a capex of approximately INR425 crores. Management noted that the hospital would initially operate 200 beds and ramp up capacity as occupancy increases. The financial performance for Q3 showed total income of INR365.3 crores, a 9.8% year-on-year increase, while PAT decreased by 18.7% year-on-year to INR42.5 crores, attributed to the new Labor Code's impact. For the nine-month period, total income rose by 15.1% year-on-year to INR1,111.9 crores. Management indicated that the Dombivli hospital would contribute to an EBITDA drag for the next two years. The call included discussions on ongoing projects in Pune and Mira Road, as well as the overall demand-supply situation in the healthcare sector.
Management highlighted both positive developments and challenges in financial performance.
Sourced from an exchange-filed transcript, dated 05 Feb 2026. Summary is RedixFi-generated and distinct from investment advice.
AI Summary of Annual Report
AI-generatedJupiter Life Line Hospitals Limited (JLHL) reported no material defaults or regulatory penalties in FY2025-26, with statutory compliance maintained. The company operates 30+ multi-speciality hospitals, focusing on clinical excellence and infrastructure expansion. Key audit matters included receivables management and provisioning, with no fraud or material misstatements identified. The auditor noted no going-concern uncertainties, and the company has no overdue statutory dues or pending litigation. JLHL’s financials show no material weaknesses in internal controls, and it has not accepted public deposits.
- No defaults or regulatory penalties noted in FY2025-26.
- Key audit focus on receivables and provisioning, with no material misstatements.
- No overdue statutory dues or pending litigation.
- Internal controls deemed adequate with no material weaknesses.
- No public deposits accepted, and no going-concern uncertainties flagged.
Key takeaway: JLHL maintains strong compliance, with no material financial or regulatory risks identified in FY2025-26.
The following annual report excerpts provide qualitative strategic context. Do not treat any specific financial figures in these excerpts as authoritative — they may be incorrectly labeled due to PDF table extraction limitations. For precise financial data, refer to the structured fundamentals data above.
Governance disclosures
AI-generatedNeeds attention
No item of a kind that needs attention was stored for this company.
Contingent Liability
3 occurrencesRecent (last 12 months)
The company has certain claims and litigations assessed as contingent liabilities, which may affect its operations. Management expects a favourable outcome based on their assessment and legal advisors' advice.
Earlier (1-3 years ago)
The company has certain claims and litigations assessed as contingent liabilities, which may affect its operations. Management expects a favourable outcome based on their assessment and legal advisors' advice.
The company has certain claims and litigations assessed as contingent liabilities, which may affect its operations. Management expects a favourable outcome based on their assessment and legal advisors' advice.
Statutory dues in dispute
1 occurrenceEarlier (1-3 years ago)
The company has statutory dues related to Service Tax, with a dispute pending before the Commissioner of Appeals Thane.